Clinical trial
Point of Care Tests for Cutaneous Leishmaniasis: Prospective Evaluation of LoopampTM and CL DetectTM Rapid Test for Cutaneous Leishmaniasis Diagnosis in Afghanistan
NCT03435419 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Point of Care Tests for Cutaneous Leishmaniasis: Prospective Evaluation of LoopampTM and CL DetectTM Rapid Test for Cutaneous Leishmaniasis Diagnosis in Afghanistan
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 16, 2016
- Completion date
- July 18, 2016
- Enrollment
- 274 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniases